Search

everythinglearnresearchcommunity

for

Search:↓

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Estrogen therapy can reduce skin aging but has cancer risks.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.